China SXT Pharmaceuticals is a drug manufacturers - specialty & generic business based in the US. China SXT Pharmaceuticals shares (SXTC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.38 – a decrease of 10.86% over the previous week. China SXT Pharmaceuticals employs 75 staff and has a trailing 12-month revenue of around $1.9 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.38 |
|---|---|
| 52-week range | $0.37 - $3.97 |
| 50-day moving average | $0.60 |
| 200-day moving average | $1.14 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-3.57 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.388 from 2024-11-19
| 1 week (2024-11-13) | -15.65% |
|---|---|
| 1 month (2024-10-18) | -38.41% |
| 3 months (2024-08-20) | -58.72% |
| 6 months (2024-05-20) | -67.93% |
| 1 year (2023-11-20) | -80.00% |
|---|---|
| 2 years (2022-11-18) | -97.50% |
| 3 years (2021-11-19) | 20.275 |
| 5 years (2019-11-20) | 84.4 |
| Revenue TTM | $1.9 million |
|---|---|
| Operating margin TTM | 733.81% |
| Gross profit TTM | $1.3 million |
| Return on assets TTM | -4.97% |
| Return on equity TTM | -21.65% |
| Profit margin | -160.67% |
| Book value | $6.28 |
| Market Capitalization | $1.7 million |
TTM: trailing 12 months
We're not expecting China SXT Pharmaceuticals to pay a dividend over the next 12 months.
China SXT Pharmaceuticals's shares were split on a 1:25 basis on 4 October 2023 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China SXT Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for China SXT Pharmaceuticals shares which in turn could have impacted China SXT Pharmaceuticals's share price.
Over the last 12 months, China SXT Pharmaceuticals's shares have ranged in value from as little as $0.3711 up to $3.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China SXT Pharmaceuticals's is 1.163. This would suggest that China SXT Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
China SXT Pharmaceuticals, Inc. , a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.